Literature DB >> 2963398

The treatment of immune glomerular disease.

D G Williams1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2963398     DOI: 10.1007/bf00197218

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  24 in total

1.  Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A.

Authors:  A Meyrier; P Simon; G Perret; M C Condamin-Meyrier
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-22

2.  Results of a controlled drug trial in membranoproliferative glomerulonephritis.

Authors:  D C Cattran; C J Cardella; J M Roscoe; R C Charron; P C Rance; S M Ritchie; P N Corey
Journal:  Kidney Int       Date:  1985-02       Impact factor: 10.612

Review 3.  Treatment of lupus nephritis.

Authors:  D G Williams
Journal:  Contrib Nephrol       Date:  1984       Impact factor: 1.580

4.  Pathogenesis of lipoid nephrosis: a disorder of T-cell function.

Authors:  R J Shalhoub
Journal:  Lancet       Date:  1974-09-07       Impact factor: 79.321

Review 5.  The syndrome of IgA nephropathy.

Authors:  A R Clarkson; A J Woodroffe; K M Bannister; J D Lomax-Smith; I Aarons
Journal:  Clin Nephrol       Date:  1984-01       Impact factor: 0.975

6.  Suppression of murine lupus nephritis by administration of an anti-idiotypic antibody to anti-DNA.

Authors:  B H Hahn; F M Ebling
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

7.  A controlled study of short-term prednisone treatment in adults with membranous nephropathy.

Authors: 
Journal:  N Engl J Med       Date:  1979-12-13       Impact factor: 91.245

8.  Plasma exchange in the treatment of mesangiocapillary glomerulonephritis.

Authors:  E McGinley; R Watkins; A McLay; J M Boulton-Jones
Journal:  Nephron       Date:  1985       Impact factor: 2.847

9.  Cyclosporin A inhibits acute serum sickness nephritis in rabbits.

Authors:  G H Neild; K Ivory; M Hiramatsu; D G Williams
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

10.  Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies.

Authors:  N E Adelman; D L Watling; H O McDevitt
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.